Regulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitin-related modifiers

Biology of the Cell

Volumn 104, Issue 3, 2012, Pages 121-138

  Wang, Yao E ^a   Pernet, Olivier ^a   Lee, Benhur ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Post translational modification; Proteasomes ubiquitin; Protein sorting trafficking targeting; Viruses

Indexed keywords

CELL PROTEIN; PROTEIN P53; SUMO PROTEIN; TAX PROTEIN; UBIQUITIN; VIRUS PROTEIN;

ADENOVIRUS 5; CELL NUCLEUS; CONJUGATION; CYTOPLASM; DNA VIRUS; EPSTEIN BARR VIRUS; HERPES VIRUS; HOST CELL; NONHUMAN; NUCLEAR IMPORT; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; RETROVIRUS; REVIEW; RNA VIRUS; UBIQUITINATION;

ANIMALS; CELL NUCLEUS; CYTOPLASM; HUMANS; PROTEIN TRANSPORT; PROTEINS; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; UBIQUITIN; VIRAL PROTEINS;

EID: 84861304624     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1111/boc.201100105     Document Type: Review

References (159)

1. Abed, M., Barry, K.C., Kenyagin, D., Koltun, B., Phippen, T.M., Delrow, J.J., Parkhurst, S.M. and Orian, A. (2011a) Degringolade, a SUMO-targeted ubiquitin ligase, inhibits hairy/groucho-mediated repression. EMBO J. 30, 1289-1301.
2. Abed, M., Bitman-Lotan, E. and Orian, A. (2011b) A fly view of a SUMO-targeted ubiquitin ligase. Fly (Austin) 5, 340-344.
3. Adamson, A.L. (2005) Effects of SUMO-1 upon Epstein-Barr virus BZLF1 function and BMRF1 expression. Biochem. Biophys. Res. Commun. 336, 22-28.
4. Adamson, A.L. and Kenney, S. (2001) Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J. Virol. 75, 2388-2399.
5. Ahn, J.H., Xu, Y., Jang, W.J., Matunis, M.J. and Hayward, G.S. (2001) Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J. Virol. 75, 3859-3872.
6. Alefantis, T., Barmak, K., Harhaj, E.W., Grant, C. and Wigdahl, B. (2003) Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax. J. Biol. Chem. 278, 21814-21822.
7. Bae, S., Jeong, J., Park, J.A., Kim, S., Bae, M., Choi, S. and Kim, K. (2004) SUMOylation increases HIF-1alpha stability and its transcriptional activity. Biochem. Biophys. Res. Commun. 324, 394-400.
8. Bandi, P., Garcia, M.L., Booth, C.J., Chisari, F.V. and Robek, M.D. (2010) Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrob. Agents Chemother. 54, 749-756.
9. Berk, A.J. (2005) Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24, 7673-7685.
10. Barry, K.C., Abed, M., Kenyagin, D., Werwie, T.R., Boico, O., Orian, A. and Parkhurst, S.M. (2011) The drosophila STUbL protein degringolade limits HES functions during embryogenesis. Development 138, 1759-1769.
11. Bex, F., McDowall, A., Burny, A. and Gaynor, R. (1997) The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 71, 3484-3497.
12. Bex, F., Murphy, K., Wattiez, R., Burny, A. and Gaynor, R.B. (1999) Phosphorylation of the human T-cell leukemia virus type 1 transactivator Tax on adjacent serine residues is critical for Tax activation. J. Virol. 73, 738-745.
13. Bieniasz, P.D. (2006) Late budding domains and host proteins in enveloped virus release. Virology 344, 55-63.
14. Boggio, R. and Chiocca, S. (2006) Viruses and SUMOylation: Recent highlights. Curr. Opin. Microbiol. 9, 430-436.
15. Burton, M., Upadhyaya, C.D., Maier, B., Hope, T.J. and Semmes, O.J. (2000) Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets. J. Virol. 74, 2351-2364.
16. Cai, Q. and Robertson, E.S. (2010) Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. PLoS ONE 5, e12636.
17. Calderwood, M.A., Holthaus, A.M. and Johannsen, E. (2008) The Epstein-Barr virus LF2 protein inhibits viral replication. J. Virol. 82, 8509-8519.
18. Carter, S., Bischof, O., Dejean, A. and Vousden, K.H. (2007) C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol. 9, 428-435.
19. Chakrabarti, S.R., Sood, R., Nandi, S. and Nucifora, G. (2000) Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. U. S. A. 97, 13281-13285.
20. Chang, L., Lee, Y., Cheng, T., Hong, Y., Lu, P., Wang, J.J., Wang, W., Kuo, C., Li, S.S. and Liu, S. (2004) Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. J. Biol. Chem. 279, 38803-38812.
21. Chang, L., Liu, S., Kuo, C., Wang, W., Chuang, J., Bianchi, E. and Hong, Y. (2008) Enhancement of transactivation activity of Rta of Epstein-Barr virus by RanBPM. J. Mol. Biol. 379, 231-242.
22. Chen, B.B. and Mallampalli, R.K. (2009) Masking of a nuclear signal motif by monoubiquitination leads to mislocalization and degradation of the regulatory enzyme cytidylyltransferase. Mol. Cell Biol. 29, 3062-3075.
23. Chen, B.J. and Lamb, R.A. (2008) Mechanisms for enveloped virus budding: Can some viruses do without an ESCRT? Virology 372, 221-232.
24. Chen, C., Sun, X., Ran, Q., Wilkinson, K.D., Murphy, T.J., Simons, J.W. and Dong, J. (2005) Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24, 3319-3327.
25. Chiari, E., Lamsoul, I., Lodewick, J., Chopin, C., Bex, F. and Pique, C. (2004) Stable ubiquitination of human T-cell leukemia virus type 1 Tax is required for proteasome binding. J. Virol. 78, 11823-11832.
26. Choi, D.W., Seo, Y., Kim, E., Sung, K.S., Ahn, J.W., Park, S., Lee, S. and Choi, C.Y. (2008) Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/socs box protein WSB-1. J. Biol. Chem. 283, 4682-4689.
27. Cole, C.N. and Hammell, C.M. (1998) Nucleocytoplasmic transport: Driving and directing transport. Curr. Biol. 8, R368-R372.
28. Comerford, K.M., Leonard, M.O., Karhausen, J., Carey, R., Colgan, S.P. and Taylor, C.T. (2003) Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 100, 986-991.
29. de Oliveira, D.E., Ballon, G. and Cesarman, E. (2010) NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 18, 248-257.
30. Denuc, A. and Marfany, G. (2010) SUMO and ubiquitin paths converge. Biochem. Soc. Trans. 38, 34-39.
31. Desterro, J.M., Rodriguez, M.S. and Hay, R.T. (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2, 233-239.
32. Dick, L.R. and Fleming, P.E. (2010) Building on bortezomib: Second-generation proteasome inhibitors as anti-cancer therapy. Drug Discov. Today 15, 243-249.
33. Du, J.X., Bialkowska, A.B., McConnell, B.B. and Yang, V.W. (2008) SUMOylation regulates nuclear localization of Krüppel-like factor 5. J. Biol. Chem. 283, 31991-32002.
34. Dudek, S.E., Luig, C., Pauli, E., Schubert, U. and Ludwig, S. (2010) The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza a virus and vesicular stomatitis virus propagation by establishing an antiviral state. J. Virol. 84, 9439-9451.
35. Duprez, E., Saurin, A.J., Desterro, J.M., Lallemand-Breitenbach, V., Howe, K., Boddy, M.N., Solomon, E., de Thé, H., Hay, R.T. and Freemont, P.S. (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein pml: Implications for nuclear localisation. J. Cell Sci. 112 (Pt 3), 381-393.
36. Endter, C., Kzhyshkowska, J., Stauber, R. and Dobner, T. (2001) SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 98, 11312-11317.
37. Fradet-Turcotte, A., Brault, K., Titolo, S., Howley, P.M. and Archambault, J. (2009) Characterization of papillomavirus e1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9. Virology 395, 190-201.
38. Fried, H. and Kutay, U. (2003) Nucleocytoplasmic transport: Taking an inventory. Cell Mol. Life Sci. 60, 1659-1688.
39. Fukuchi, M., Imamura, T., Chiba, T., Ebisawa, T., Kawabata, M., Tanaka, K. and Miyazono, K. (2001) Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol. Biol. Cell 12, 1431-1443.
40. Gareau, J.R. and Lima, C.D. (2010) The SUMO pathway: Emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861-871.
41. Garrus, J.E., von Schwedler, U.K., Pornillos, O.W., Morham, S.G., Zavitz, K.H., Wang, H.E., Wettstein, D.A., Stray, K.M., Côté, M., Rich, R.L., Myszka, D.G. and Sundquist, W.I. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65.
42. Gatza, M.L., Dayaram, T. and Marriott, S.J. (2007) Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export. Retrovirology 4, 95.
43. Gatza, M.L. and Marriott, S.J. (2006) Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 Tax through a CRM1-dependent mechanism. J. Virol. 80, 6657-6668.
44. Geoffroy, M. and Hay, R.T. (2009) An additional role for SUMO in ubiquitin-mediated proteolysis. Nat. Rev. Mol. Cell Biol. 10, 564-568.
45. Ghildyal, R., Baulch-Brown, C., Mills, J. and Meanger, J. (2003) The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch. Virol. 148, 1419-1429.
46. Goodbourn, S. and Randall, R.E. (2009) The regulation of type I interferon production by paramyxoviruses. J. Interferon Cytokine Res. 29, 539-547.
47. Görlich, D. and Kutay, U. (1999) Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15, 607-660.
48. Gravel, A., Dion, V., Cloutier, N., Gosselin, J. and Flamand, L. (2004) Characterization of human herpesvirus 6 variant b immediate-early 1 protein modifications by small ubiquitin-related modifiers. J. Gen. Virol. 85, 1319-1328.
49. Griffin, D.E., Lamb, M.A., Martin, M.A., Roizman, B. and Straus, S.E. (2007) Fields virology. In Virus Replication Strategies. Knipe D.M. and Howley P.M. (eds.). Wolters Kluwer, Lippincott, Williams & Wilkins, Philadelphia, PA, 119-140.
50. Groulx, I. and Lee, S. (2002) Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell Biol. 22, 5319-5336.
51. Gustin, J.K., Moses, A.V., Früh, K. and Douglas, J.L. (2011) Viral takeover of the host ubiquitin system. Front. Microbiol. 2, 161.
52. Güttler, T. and Görlich, D. (2011) Ran-dependent nuclear export mediators: A structural perspective. EMBO J. 30, 3457-3474.
53. Hagemeier, S.R., Dickerson, S.J., Meng, Q., Yu, X., Mertz, J.E. and Kenney, S.C. (2010) SUMOylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase. J. Virol. 84, 4383-4394.
54. Haoudi, A., Daniels, R.C., Wong, E., Kupfer, G. and Semmes, O.J. (2003) Human T-cell leukemia virus-I Tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J. Biol. Chem. 278, 37736-37744.
55. Heilmann, A.M.F., Calderwood, M.A. and Johannsen, E. (2010) Epstein-Barr virus LF2 protein regulates viral replication by altering rta subcellular localization. J. Virol. 84, 9920-9931.
56. Hofmann, H., Flöss, S. and Stamminger, T. (2000) Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J. Virol. 74, 2510-2524.
57. Honda, R., Tanaka, H. and Yasuda, H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
58. Huang, T.T., Wuerzberger-Davis, S.M., Wu, Z. and Miyamoto, S. (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115, 565-576.
59. Ikeda, M., Ikeda, A. and Longnecker, R. (2001) PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. J. Virol. 75, 5711-5718.
60. Ikeda, M., Ikeda, A. and Longnecker, R. (2002) Lysine-independent ubiquitination of Epstein-Barr virus LMP2A. Virology 300, 153-159.
61. Imoto, S., Ohbayashi, N., Ikeda, O., Kamitani, S., Muromoto, R., Sekine, Y. and Matsuda, T. (2008) SUMOylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling. Biochem. Biophys. Res. Commun. 370, 359-365.
62. Izumiya, Y., Ellison, T.J., Yeh, E.T.H., Jung, J.U., Luciw, P.A. and Kung, H. (2005) Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J. Virol. 79, 9912-9925.
63. Jamali, T., Jamali, Y., Mehrbod, M. and Mofrad, M.R.K. (2011) Nuclear pore complex: Biochemistry and biophysics of nucleocytoplasmic transport in health and disease. Int. Rev. Cell Mol. Biol. 287, 233-286.
64. Jans, D.A. and Hübner, S. (1996) Regulation of protein transport to the nucleus: Central role of phosphorylation. Physiol. Rev. 76, 651-685.
65. Jeang, K. (2010) HTLV-1 and adult T-cell leukemia: Insights into viral transformation of cells 30 years after virus discovery. J. Formos. Med. Assoc. 109, 688-693.
66. Katze, M.G., He, Y. and Gale, M.J. (2002) Viruses and interferon: A fight for supremacy. Nat. Rev. Immunol. 2, 675-687.
67. Kerscher, O., Felberbaum, R. and Hochstrasser, M. (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22, 159-180.
68. Kfoury, Y., Nasr, R., Favre-Bonvin, A., El-Sabban, M., Renault, N., Giron, M., Setterblad, N., Hajj, H.E., Chiari, E., Mikati, A.G., Hermine, O., Saib, A., de Thé, H., Pique, C. and Bazarbachi, A. (2008) Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome. Oncogene 27, 1665-1676.
69. Kfoury, Y., Setterblad, N., El-Sabban, M., Zamborlini, A., Dassouki, Z., El Hajj, H., Hermine, O., Pique, C., de Thé, H., Saïb, A. and Bazarbachi, A. (2011) Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome. Blood 117, 190-199.
70. Kim, Y.H., Choi, C.Y. and Kim, Y. (1999) Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl. Acad. Sci. U. S. A. 96, 12350-12355.
71. Kindsmüller, K., Groitl, P., Härtl, B., Blanchette, P., Hauber, J. and Dobner, T. (2007) Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc. Natl. Acad. Sci. U. S. A. 104, 6684-6689.
72. Krätzer, F., Rosorius, O., Heger, P., Hirschmann, N., Dobner, T., Hauber, J. and Stauber, R.H. (2000) The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 19, 850-857.
73. Kupperman, E., Lee, E.C., Cao, Y., Bannerman, B., Fitzgerald, M., Berger, A., Yu, J., Yang, Y., Hales, P., Bruzzese, F., Liu, J., Blank, J., Garcia, K., Tsu, C., Dick, L., Fleming, P., Yu, L., Manfredi, M., Rolfe, M. and Bolen, J. (2010) Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer. Cancer Res. 70, 1970-1980.
74. Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B. and de Thé, H. (2008) Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10, 547-555.
75. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P.P., Puvion, E., Freemont, P. and de Thé, H. (2001) Role of promyelocytic leukemia (Pml) SUMOlation in nuclear body formation, 11s proteasome recruitment, and as2o3-induced Pml or Pml/retinoic acid receptor alpha degradation. J. Exp. Med. 193, 1361-1371.
76. Lamsoul, I., Lodewick, J., Lebrun, S., Brasseur, R., Burny, A., Gaynor, R.B. and Bex, F. (2005) Exclusive ubiquitination and SUMOylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus Tax oncoprotein. Mol. Cell Biol. 25, 10391-10406.
77. Lee, J.C., Wang, G.X., Schickling, O. and Peter, M.E. (2005) Fusing DEDD with ubiquitin changes its intracellular localization and apoptotic potential. Apoptosis 10, 1483-1495.
78. Lee, J.T. and Gu, W. (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86-92.
79. Lee, P.S.W., Chang, C., Liu, D. and Derynck, R. (2003) SUMOylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J. Biol. Chem. 278, 27853-27863.
80. Li, M., Brooks, C.L., Wu-Baer, F., Chen, D., Baer, R. and Gu, W. (2003) Mono- versus polyubiquitination: Differential control of p53 fate by Mdm2. Science 302, 1972-1975.
81. Lin, X., Liang, M., Liang, Y., Brunicardi, F.C. and Feng, X. (2003a) SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278, 31043-31048.
82. Lin, X., Sun, B., Liang, M., Liang, Y., Gast, A., Hildebrand, J., Brunicardi, F.C., Melchior, F. and Feng, X. (2003b) Opposed regulation of corepressor CtBP by SUMOylation and pdz binding. Mol. Cell 11, 1389-1396.
83. Liu, F. and Walters, K.J. (2010) Multitasking with ubiquitin through multivalent interactions. Trends Biochem. Sci. 35, 352-360.
84. Lodewick, J., Lamsoul, I., Polania, A., Lebrun, S., Burny, A., Ratner, L. and Bex, F. (2009) Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. Virology 386, 68-78.
85. Lohrum, M.A., Woods, D.B., Ludwig, R.L., Bálint, E. and Vousden, K.H. (2001) C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell Biol. 21, 8521-8532.
86. Ma, X., Bartczak, A., Zhang, J., Khattar, R., Chen, L., Liu, M.F., Edwards, A., Levy, G. and McGilvray, I.D. (2010) Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome. J. Virol. 84, 12419-12428.
87. Mahajan, R., Delphin, C., Guan, T., Gerace, L. and Melchior, F. (1997) A small ubiquitin-related polypeptide involved in targeting rangap1 to nuclear pore complex protein ranbp2. Cell 88, 97-107.
88. Malcles, M., Cueille, N., Mechali, F., Coux, O. and Bonne-Andrea, C. (2002) Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway. J. Virol. 76, 11350-11358.
89. Martin-Serrano, J. (2007) The role of ubiquitin in retroviral egress. Traffic 8, 1297-1303.
90. Martin-Serrano, J., Zang, T. and Bieniasz, P.D. (2001) HIV-1 and ebola virus encode small peptide motifs that recruit tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313-1319.
91. Matsuoka, M. and Jeang, K. (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: Viral infectivity, Tax, hbz and therapy. Oncogene 30, 1379-1389.
92. Mattaj, I.W. and Englmeier, L. (1998) Nucleocytoplasmic transport: The soluble phase. Annu. Rev. Biochem. 67, 265-306.
93. Matunis, M.J., Coutavas, E. and Blobel, G. (1996) A novel ubiquitin-like modification modulates the partitioning of the ran-GTPase-activating protein rangap1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470.
94. Matunis, M.J., Wu, J. and Blobel, G. (1998) SUMO-1 modification and its role in targeting the ran GTPase-activating protein, rangap1, to the nuclear pore complex. J. Cell Biol. 140, 499-509.
95. McDonald, B. and Martin-Serrano, J. (2009) No strings attached: The ESCRT machinery in viral budding and cytokinesis. J. Cell Sci. 122, 2167-2177.
96. Meertens, L., Chevalier, S., Weil, R., Gessain, A. and Mahieux, R. (2004) A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 Tax protein sequences is responsible for their divergent subcellular distribution. J. Biol. Chem. 279, 43307-43320.
97. Morén, A., Hellman, U., Inada, Y., Imamura, T., Heldin, C. and Moustakas, A. (2003) Differential ubiquitination defines the functional status of the tumor suppressor Smad4. J. Biol. Chem. 278, 33571-33582.
98. Moroianu, J. (1999) Nuclear import and export pathways. J. Cell Biochem. Suppl 32-33, 76-83.
99. Mukhopadhyay, D., Arnaoutov, A. and Dasso, M. (2010) The SUMO protease senp6 is essential for inner kinetochore assembly. J. Cell Biol. 188, 681-692.
100. Müller, S., Matunis, M.J. and Dejean, A. (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of Pml within the nucleus. EMBO J. 17, 61-70.
101. Nakamura, S., Roth, J.A. and Mukhopadhyay, T. (2002) Multiple lysine mutations in the c-terminus of p53 make it resistant to degradation mediated by Mdm2 but not by human papillomavirus e6 and induce growth inhibition in Mdm2-overexpressing cells. Oncogene 21, 2605-2610.
102. Nasr, R., Chiari, E., El-Sabban, M., Mahieux, R., Kfoury, Y., Abdulhay, M., Yazbeck, V., Hermine, O., de Thé, H., Pique, C. and Bazarbachi, A. (2006) Tax ubiquitylation and SUMOylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood 107, 4021-4029.
103. Nejmeddine, M., Barnard, A.L., Tanaka, Y., Taylor, G.P. and Bangham, C.R.M. (2005) Human t-lymphotropic virus, type 1, Tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 280, 29653-29660.
104. Nevels, M., Brune, W. and Shenk, T. (2004) SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J. Virol. 78, 7803-7812.
105. Neznanov, N., Dragunsky, E.M., Chumakov, K.M., Neznanova, L., Wek, R.C., Gudkov, A.V. and Banerjee, A.K. (2008) Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication. PLoS ONE 3, e1887.
106. Peeples, M.E. (1988) Differential detergent treatment allows immunofluorescent localization of the Newcastle disease virus matrix protein within the nucleus of infected cells. Virology 162, 255-259.
107. Peeples, M.E., Wang, C., Gupta, K.C. and Coleman, N. (1992) Nuclear entry and nucleolar localization of the Newcastle disease virus (NDV) matrix protein occur early in infection and do not require other NDV proteins. J. Virol. 66, 3263-3269.
108. Peloponese, J.J., Iha, H., Yedavalli, V.R.K., Miyazato, A., Li, Y., Haller, K., Benkirane, M. and Jeang, K. (2004) Ubiquitination of human T-cell leukemia virus type 1 Tax modulates its activity. J. Virol. 78, 11686-11695.
109. Petersen, J.M., Her, L.S., Varvel, V., Lund, E. and Dahlberg, J.E. (2000) The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol. Cell Biol. 20, 8590-8601.
110. Pichler, A., Gast, A., Seeler, J.S., Dejean, A. and Melchior, F. (2002) The nucleoporin ranbp2 has SUMO1 e3 ligase activity. Cell 108, 109-120.
111. Pichler, A. and Melchior, F. (2002) Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic 3, 381-387.
112. Prudden, J., Pebernard, S., Raffa, G., Slavin, D.A., Perry, J.J.P., Tainer, J.A., McGowan, C.H. and Boddy, M.N. (2007) SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26, 4089-4101.
113. Raaben, M., Posthuma, C.C., Verheije, M.H., te Lintelo, E.G., Kikkert, M., Drijfhout, J.W., Snijder, E.J., Rottier, P.J.M. and de Haan, C.A.M. (2010) The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J. Virol. 84, 7869-7879.
114. Ramachandran, A. and Horvath, C.M. (2009) Paramyxovirus disruption of interferon signal transduction: Status report. J. Interferon Cytokine Res. 29, 531-537.
115. Rangasamy, D. and Wilson, V.G. (2000) Bovine papillomavirus e1 protein is SUMOylated by the host cell Ubc9 protein. J. Biol. Chem. 275, 30487-30495.
116. Rangasamy, D., Woytek, K., Khan, S.A. and Wilson, V.G. (2000) SUMO-1 modification of bovine papillomavirus e1 protein is required for intranuclear accumulation. J. Biol. Chem. 275, 37999-38004.
117. Rodriguez, M.S., Desterro, J.M., Lain, S., Lane, D.P. and Hay, R.T. (2000) Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell Biol. 20, 8458-8467.
118. Rosas-Acosta, G., Langereis, M.A., Deyrieux, A. and Wilson, V.G. (2005) Proteins of the pias family enhance the SUMOylation of the papillomavirus e1 protein. Virology 331, 190-203.
119. Rosas-Acosta, G. and Wilson, V.G. (2008) Identification of a nuclear export signal sequence for bovine papillomavirus e1 protein. Virology 373, 149-162.
120. Rosendorff, A., Illanes, D., David, G., Lin, J., Kieff, E. and Johannsen, E. (2004) EBNA3c coactivation with EBNA2 requires a SUMO homology domain. J. Virol. 78, 367-377.
121. Ross, S., Best, J.L., Zon, L.I. and Gill, G. (2002) SUMO-1 modification represses sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10, 831-842.
122. Sachdev, S., Bruhn, L., Sieber, H., Pichler, A., Melchior, F. and Grosschedl, R. (2001) Piasy, a nuclear matrix-associated SUMO e3 ligase, represses lef1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088-3103.
123. Saha, A., Murakami, M., Kumar, P., Bajaj, B., Sims, K. and Robertson, E.S. (2009) Epstein-Barr virus nuclear antigen 3c augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating mdm2. J. Virol. 83, 4652-4669.
124. Sapetschnig, A., Rischitor, G., Braun, H., Doll, A., Schergaut, M., Melchior, F. and Suske, G. (2002) Transcription factor sp3 is silenced through SUMO modification by pias1. EMBO J. 21, 5206-5215.
125. Schmitt, A.P., Leser, G.P., Waning, D.L. and Lamb, R.A. (2002) Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76, 3952-3964.
126. Sehat, B., Andersson, S., Vasilcanu, R., Girnita, L. and Larsson, O. (2007) Role of ubiquitination in IGF-1 receptor signaling and degradation. PLoS ONE 2, e340.
127. Sehat, B., Tofigh, A., Lin, Y., Trocmé, E., Liljedahl, U., Lagergren, J. and Larsson, O. (2010) SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci. Signal. 3, ra10.
128. Semmes, O.J., Majone, F., Cantemir, C., Turchetto, L., Hjelle, B. and Jeang, K.T. (1996) HTLV-I and HTLV-II Tax: Differences in induction of micronuclei in cells and transcriptional activation of viral LTRs. Virology 217, 373-379.
129. Shaw, M.L., Cardenas, W.B., Zamarin, D., Palese, P. and Basler, C.F. (2005) Nuclear localization of the Nipah virus w protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J. Virol. 79, 6078-6088.
130. Shaw, M.L., García-Sastre, A., Palese, P. and Basler, C.F. (2004) Nipah virus v and w proteins have a common stat1-binding domain yet inhibit stat1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 78, 5633-5641.
131. Shcherbik, N. and Haines, D.S. (2004) Ub on the move. J. Cell Biochem. 93, 11-19.
132. Shembade, N. and Harhaj, E.W. (2010) Role of post-translational modifications of HTLV-1 Tax in NF-κB activation. World J. Biol. Chem. 1, 13-20.
133. Smith, M.R. and Greene, W.C. (1990) Identification of HTLV-I Tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4, 1875-1885.
134. Smith, M.R. and Greene, W.C. (1992) Characterization of a novel nuclear localization signal in the HTLV-I Tax transactivator protein. Virology 187, 316-320.
135. Sobko, A., Ma, H. and Firtel, R.A. (2002) Regulated SUMOylation and ubiquitination of ddmek1 is required for proper chemotaxis. Dev. Cell 2, 745-756.
136. Song, M.S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J. and Pandolfi, P.P. (2008) The deubiquitinylation and localization of pten are regulated by a HAUSP-Pml network. Nature 455, 813-817.
137. Sorokin, A.V., Kim, E.R. and Ovchinnikov, L.P. (2007) Nucleocytoplasmic transport of proteins. Biochemistry (Mosc.) 72, 1439-1457.
138. Speck, S.H., Chatila, T. and Flemington, E. (1997) Reactivation of Epstein-Barr virus: Regulation and function of the BZLF1 gene. Trends Microbiol. 5, 399-405.
139. Spengler, M.L., Kurapatwinski, K., Black, A.R. and Azizkhan-Clifford, J. (2002) SUMO-1 modification of human cytomegalovirus IE1/IE72. J. Virol. 76, 2990-2996.
140. Stehmeier, P. and Muller, S. (2009) Regulation of p53 family members by the ubiquitin-like SUMO system. DNA Repair (Amst.) 8, 491-498.
141. Tatham, M.H., Geoffroy, M., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E.G., Palvimo, J.J. and Hay, R.T. (2008) Rnf4 is a poly-SUMO-specific e3 ubiquitin ligase required for arsenic-induced pml degradation. Nat. Cell Biol. 10, 538-546.
142. Taylor, C.T., Furuta, G.T., Synnestvedt, K. and Colgan, S.P. (2000) Phosphorylation-dependent targeting of camp response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc. Natl. Acad. Sci. U. S. A. 97, 12091-12096.
143. Teale, A., Campbell, S., Van Buuren, N., Magee, W.C., Watmough, K., Couturier, B., Shipclark, R. and Barry, M. (2009) Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication. J. Virol. 83, 2099-2108.
144. Trotman, L.C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N.P., Carver, B.S., Cordon-Cardo, C., Erdjument-Bromage, H., Tempst, P., Chi, S., Kim, H., Misteli, T., Jiang, X. and Pandolfi, P.P. (2007) Ubiquitination regulates pten nuclear import and tumor suppression. Cell 128, 141-156.
145. Ulrich, H.D. (2005) Mutual interactions between the SUMO and ubiquitin systems: A plea of no contest. Trends Cell Biol. 15, 525-532.
146. von Kobbe C, van Deursen JM, Rodrigues, J.P., Sitterlin, D., Bachi, A., Wu, X., Wilm, M., Carmo-Fonseca, M. and Izaurralde, E. (2000) Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin nup98. Mol. Cell 6, 1243-1252.
147. Wang, Y.E., Park, A., Lake, M., Pentecost, M., Torres, B., Yun, T.E., Wolf, M.C., Holbrook, M.R., Freiberg, A.N. and Lee, B. (2010) Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog. 6, e1001186.
148. Wilkinson, K.D., Urban, M.K. and Haas, A.L. (1980) Ubiquitin is the atp-dependent proteolysis factor i of rabbit reticulocytes. J. Biol. Chem. 255, 7529-7532.
149. Wilson, V.G. and Rangasamy, D. (2001) Intracellular targeting of proteins by SUMOylation. Exp. Cell Res. 271, 57-65.
150. Wilson, V.G., West, M., Woytek, K. and Rangasamy, D. (2002) Papillomavirus e1 proteins: Form, function, and features. Virus Genes 24, 275-290.
151. Wirblich, C., Tan, G.S., Papaneri, A., Godlewski, P.J., Orenstein, J.M., Harty, R.N. and Schnell, M.J. (2008) Ppey motif within the rabies virus (rv) matrix protein is essential for efficient virion release and rv pathogenicity. J. Virol. 82, 9730-9738.
152. Wood, L.D., Irvin, B.J., Nucifora, G., Luce, K.S. and Hiebert, S.W. (2003) Small ubiquitin-like modifier conjugation regulates nuclear export of tel, a putative tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 100, 3257-3262.
153. Yasuda, J., Nakao, M., Kawaoka, Y. and Shida, H. (2003) NEDD4 regulates egress of ebola virus-like particles from host cells. J. Virol. 77, 9987-9992.
154. Yoshida, T., Nagai Y'Yoshii, S., Maeno, K. and Matsumoto, T. (1976) Membrane (m) protein of hvj (sendai virus): Its role in virus assembly. Virology 71, 143-161.
155. Yu, L., Mohanram, V., Simonson, O.E., Smith, C.I.E., Spetz, A. and Mohamed, A.J. (2009) Proteasome inhibitors block HIV-1 replication by affecting both cellular and viral targets. Biochem. Biophys. Res. Commun. 385, 100-105.
156. Yuan, J., Luo, K., Zhang, L., Cheville, J.C. and Lou, Z. (2010) Usp10 regulates p53 localization and stability by deubiquitinating p53. Cell 140, 384-396.
157. Zhong, S., Müller, S., Ronchetti, S., Freemont, P.S., Dejean, A. and Pandolfi, P.P. (2000) Role of SUMO-1-modified Pml in nuclear body formation. Blood 95, 2748-2752.
158. Zhou, H., Aujay, M.A., Bennett, M.K., Dajee, M., Demo, S.D., Fang, Y., Ho, M.N., Jiang, J., Kirk, C.J., Laidig, G.J., Lewis, E.R., Lu, Y., Muchamuel, T., Parlati, F., Ring, E., Shenk, K.D., Shields, J., Shwonek, P.J., Stanton, T., Sun, C.M., Sylvain, C., Woo, T.M. and Yang, J. (2009) Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (pr-047). J. Med. Chem. 52, 3028-3038.
159. Zhu, L., Santos, N.C. and Kim, K.H. (2009) Small ubiquitin-like modifier-2 modification of retinoic acid receptor-alpha regulates its subcellular localization and transcriptional activity. Endocrinology 150, 5586-5595.